Patients Want Breast Cancer Costs Upfront

FRIDAY, Sept. 28, 2018 (HealthDay News) — The cost of breast cancer treatment rarely comes up in doctor-patient discussions — but most patients wish it would, researchers report. “Doctors and patients should be open to discussing the financial implications of treatment,” said study author Dr. Rachel Greenup, of the Duke Cancer Institute in Durham, N.C.…

Bills Mount for Breast Cancer Survivors

FRIDAY, Aug. 24, 2018 (HealthDay News) — Surviving breast cancer is certainly its own reward, but a new study finds that many who do are saddled with thousands in out-of-pocket expenses for years. On average, breast cancer survivors get hit with an extra $1,100 in yearly out-of-pocket cancer-driven costs, researchers found. But interviews with 129…

Breast Cancer Drug Promising in Phase 3 Trial

WEDNESDAY, Aug. 15, 2018 (HealthDay News) — For women with advanced breast cancer who carry the BRCA1 and BRCA2 gene mutations, an experimental drug could improve survival, a new study suggests. The BRCA mutations are linked with a greater risk for aggressive breast and ovarian cancer. The drug, talazoparib, works by blocking an enzyme called…

Triple-Negative Breast Cancer Genes ID'd

WEDNESDAY, Aug. 8, 2018 (HealthDay News) — More genes associated with an increased risk of triple-negative breast cancer have been identified by researchers. Until now, only mutations in the BRCA1 gene have been linked with this type of breast cancer. “Triple-negative breast cancer is an aggressive type of cancer that cannot be treated using targeted…